Wells Fargo Maintains Equal-Weight on Integra Lifesciences, Raises Price Target to $18

Benzinga · 3d ago
Wells Fargo analyst Larry Biegelsen maintains Integra Lifesciences (NASDAQ:IART) with a Equal-Weight and raises the price target from $15 to $18.